Agenus, Inc. (AGEN) Starts Presentation at 25th Annual ROTH Conference

Agenus, Inc. (AGEN) is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including a number of product candidates that have advanced into late-stage clinical trials through corporate partners. For more information, visit the company’s Web site at http://www.agenusbio.com